Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis
NL Pereira, C Rihal, R Lennon, G Marcus… - Cardiovascular …, 2021 - jacc.org
Objectives The aim of this study was to examine the effect of CYP2C19 genotype on clinical
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis
NL Pereira, C Rihal, R Lennon… - JACC …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives The aim of this study was to examine the effect of CYP2C19 genotype on clinical
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis.
NL Pereira, C Rihal, R Lennon, G Marcus… - JACC …, 2021 - europepmc.org
Objectives The aim of this study was to examine the effect of CYP2C19 genotype on clinical
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis
NL Pereira, C Rihal, R Lennon… - JACC …, 2021 - mayoclinic.pure.elsevier.com
Objectives: The aim of this study was to examine the effect of CYP2C19 genotype on clinical
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
[引用][C] Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy
NL Pereira, C Rihal, R Lennon, G Marcus… - JACC: Cardiovascular …, 2021 - cir.nii.ac.jp
[HTML][HTML] Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis
NL Pereira, C Rihal, R Lennon, G Marcus… - JACC: Cardiovascular …, 2021 - Elsevier
Objectives The aim of this study was to examine the effect of CYP2C19 genotype on clinical
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis
NL Pereira, C Rihal, R Lennon… - JACC …, 2021 - mayoclinic.elsevierpure.com
Objectives: The aim of this study was to examine the effect of CYP2C19 genotype on clinical
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
[HTML][HTML] Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis
NL Pereira, C Rihal, R Lennon, G Marcus… - JACC …, 2021 - ncbi.nlm.nih.gov
BACKGROUND The effect of CYP2C19 genotype on treatment outcomes with ticagrelor or
prasugrel as compared to clopidogrel is unclear. METHODS Databases through February …
prasugrel as compared to clopidogrel is unclear. METHODS Databases through February …
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis.
NL Pereira, C Rihal, R Lennon, G Marcus… - JACC …, 2021 - europepmc.org
Objectives The aim of this study was to examine the effect of CYP2C19 genotype on clinical
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …